Equal access to treatment? Population-based follow-up of drugs dispensed to patients after acute myocardial infarction in Sweden

European Journal of Clinical Pharmacology

Volumn 64, Issue 4, 2008, Pages 417-424

  Ringback Weitoft G ^a   Ericsson, O ^a   Lofroth E ^a,b   Rosen M ^b,c  

^a CENTRE FOR EPIDEMIOLOGY   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c Swedish Council on Technology Assessment in Health Care   (Sweden)

Author keywords

AMI; Dispensed drugs; Education; Equity; Ethnicity; Prescription database

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BIRTHPLACE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; EDUCATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK; SEX; SOCIOECONOMICS; SWEDEN;

ACUTE DISEASE; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTILIPEMIC AGENTS; DIABETES MELLITUS; DRUG UTILIZATION; EDUCATION; FEMALE; FOLLOW-UP STUDIES; GUIDELINES AS TOPIC; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; POPULATION; SEX FACTORS; SOCIOECONOMIC FACTORS; SWEDEN;

EID: 40049102154     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-007-0425-y     Document Type: Article

References (25)

1. Rosén M (1988) Epidemiological measures in planning: observations from Sweden. Int J Health Plan Manage 3:261-270
2. Haglund B (1994) Vård på lika villkor (Equal access to care) (in Swedish). EpC-report 1994:3. The Swedish National Board of Health and Welfare, Stockholm
3. Hjern A, Haglund B, Persson G, Rosén M (2001) Is there equity in access to health services for ethnic minorities in Sweden? Eur J Public Health 11:147-152
4. Whitehead M, Evandrou M, Haglund B, Diderichsen F (1997) As the health divide widens in Sweden and Britain, what's happening to access to care? Br Med J 315:1006-1009
5. Haglund B, Köster M, Nilsson T, Rosén M (2004) Inequality in access to coronary revascularization in Sweden. Scand Cardiovasc J 38:334-339
6. Hjern A, Haglund B, Rasmussen F, Rosén M (2000) Socio-economic differences in daycare arrangements and use of medical care and antibiotics in Swedish preschool children. Acta Paediatr 89:1250-1256
7. Gorecka K, Linhartova A, Vlcek J, Tilser I (2005) Cardiovascular drug utilisation and socio-economic inequalities in 20 districts of the Czech Republic. Eur J Clin Pharmacol 61:417-423
8. Stocks NP, Ryan P, McElroy H, Allan J (2004). Statin prescribing in Australia: socioeconomic and sex differences. A cross-sectional study. Med J Aust 180:229-231
9. Melander E, Nissen A, Henricson K et al (2003) Utilisation of antibiotics in young children: opposite relationships to adult educational level in Danish and Swedish counties. Eur J Clin Pharmacol 59:331-335
10. Tobi H, Meijer WM, Tuinstra J, de Jong-van den Berg LT (2003) Socio-economic differences in prescription and OTC drug use in Dutch adolescents. Pharm World Sci 25:203-206
11. Lundberg L, Johannesson M, Isacson DG, Borgquist L (1998) Effects of user charges on the use of prescription medicines in different socio-economic groups. Health Policy 44:123-134
12. De Backer G, Ambrosioni E, Borch-Johnsen K et al (2003) European guidelines on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehab 10[Suppl 1]:S1-S78
13. Swedish National Board of Health and Welfare (2004) Socialstyrelsens riktlinjer för hjärtsjukvård (Guidelines on cardiovascular disease) (in Swedish). The Swedish National Board of Health and Welfare, Stockholm
14. Opolka JL, Rascati KL, Brown CM, Gibson PJ (2004) Ethnicity and prescription patterns for haloperidol, risperidone, and olazapine. Psychiatr Serv 55:151-156
15. Kuno E, Rothbard AB (2002) Racial disparities in antipsychotic prescription patterns for patients with schizophrenia. Am J Psychiatry 159:567-572
16. Vaccarino V, Rathore SS, Wenger NK et al (2005) Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med 353:671-682
17. Canto JG, Allison JJ, Kiefe CI et al (2000) Relation of race and sex to the use of reperfusion therapy in Medicare beneficiaries with acute myocardial infarction. N Engl J Med 342:1094-1100
18. Rathore SS, Berger AK, Weinfurt KP et al (2000) Race, sex, poverty, and the medical treatment of acute myocardial infarction in the elderly. Circulation 102:642-648
19. EUROASPIRE II Study Group (2001) Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 22:554-572
20. Pyorala K, Lehto S, De Bacquer D et al (2004) Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I and II surveys. Diabetologica 47:1257-1265
21. Mayer O Jr, Simon J, Heidrich J, Cokkinos DV, De Baquer D, EUROASPIRE II Study Group (2004). Educational level and risk profile of cardiac patients in the EUROASPIRE II substudy. J Epidemiol Community Health 58:47-52
22. EUROASPIRE I and II Group (2001) Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events. Lancet 357:995-1001
23. Eliasson M, Janlert U, Jansson JH, Stegmayr B (2006) Time trends in population cholesterol levels 1986-2004: influence of lipid-lowering drugs, obesity, smoking and educational level. The northern Sweden MONICA study. J Intern Med 260:551-559
24. Helman CG (Ed) (2000) Culture, health and illness, 4th edn. Butterworth Heineman, Oxford
25. Ringbäck Weitoft G, Gullberg A, Hjern A, Rosén M (1999) Mortality statistics in immigrant research: method for adjusting underestimation of mortality. Int J Epidemiol 28:756-763